About the Authors

Peter Recknagel, Falk A. Gonnert, Sandro Lambeck, Andreas Kortgen, Christoph Sponholz, Ralf A. Claus, Niels C. Riedemann, Michael Bauer
Integrated Research and Treatment Center, Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany

Peter Recknagel, Alain Rudiger, Alex Dyson, Jane E. Carré, Mervyn Singer
Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, United Kingdom

Martin Westermann
Electron Microscopy Center, Jena University Hospital, Jena, Germany

Amelie Lupp
Department of Pharmacology and Toxicology, Jena University Hospital, Jena, Germany

Christoph Krafft, Jürgen Popp
Institute of Photonic Technology, Jena, Germany

Valentin Fuhrmann, Michael Trauner
Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Ingrid Hilger
Institute of Diagnostic and Interventional Radiology, Jena University Hospital, Jena, Germany

Reinhard Wetzker
Department of Molecular Cell Biology, Center for Molecular Biomedicine, Jena University Hospital, Jena, Germany

Corresponding Author

Michael.Bauer@med.uni-jena.de

Competing Interests

The authors declare that a patent has been filed regarding the use of bile acids for the diagnosis of sepsis (MB). MS is a member of the Editorial Board of PLOS Medicine. The authors declare that no other competing interests exist.

Author Contributions

Conceived and designed the experiments: PR FAG AK JP IH RAC NCR RW MS MT MB. Performed the experiments: PR FAG MW AL AR AD JEC CK CS VF. Analyzed the data: PR FAG MW SL CK. Contributed reagents/materials/analysis tools: SL CK JP IH MT RW. Wrote the first draft of the manuscript: PR FAG MS MT MB. Contributed to the writing of the manuscript: PR FAG RW MS MT MB. ICMJE criteria for authorship read and met: PR FAG MW SL AL AR AD JEC AK CK JP CS VF IH RAC NCR RW MS MT MB. Agree with manuscript results and conclusions: PR FAG MW SL AL AR AD JEC AK CK JP CS VF IH RAC NCR RW MS MT MB.